Literature DB >> 10910416

A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults.

M Mauricio1, R O'Hara, J A Yesavage, L Friedman, H C Kraemer, M Van De Water, G M Murphy.   

Abstract

The Apolipoprotein-E (APOE) epsilon 4 allele is a risk factor for Alzheimer's disease (AD) and cognitive decline in older adults. Depression may also be a risk factor for dementia, and depression is important in the differential diagnosis of dementia. The authors performed a 5-year longitudinal study of APOE genotype and change in Geriatric Depression Scale scores in 113 community-dwelling older adults. No association was observed between APOE genotype and change in depressive symptoms. These results do not support the hypothesis that the APOE epsilon 4 allele is associated with depression. Important objections have been raised to APOE genotyping in the diagnosis of AD. However, the specificity of APOE genotyping in AD diagnosis would not appear to be compromised by an association with depression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910416

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  15 in total

1.  The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease.

Authors:  A L Pritchard; J Harris; C W Pritchard; J Coates; S Haque; R Holder; P Bentham; C L Lendon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

2.  Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease.

Authors:  N Scarmeas; J Brandt; M Albert; D P Devanand; K Marder; K Bell; A Ciappa; B Tycko; Y Stern
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

3.  Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.

Authors:  Wei Qiao Qiu; Haihao Zhu; Michael Dean; Zhiheng Liu; Linh Vu; Guanguang Fan; Huajie Li; Mkaya Mwamburi; David C Steffens; Rhoda Au
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-06       Impact factor: 3.485

4.  Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.

Authors:  Xiaoyan Sun; Chi Chia Chiu; Elizabeth Liebson; Natalia A Crivello; Lixia Wang; Joshua Claunch; Marshal Folstein; Irwin Rosenberg; D Mkaya Mwamburi; Inga Peter; Wei Qiao Qiu
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

5.  Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.

Authors:  Helen Lavretsky; Linda Ercoli; Prabha Siddarth; Susan Bookheimer; Karen Miller; Gary Small
Journal:  Am J Geriatr Psychiatry       Date:  2003 Nov-Dec       Impact factor: 4.105

6.  Resolving the relationship between ApolipoproteinE and depression.

Authors:  Michael A Slifer; Eden R Martin; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Neurosci Lett       Date:  2009-03-06       Impact factor: 3.046

7.  ApoE alleles, depression and positive affect in multiple sclerosis.

Authors:  L J Julian; L Vella; D Frankel; S L Minden; J R Oksenberg; D C Mohr
Journal:  Mult Scler       Date:  2009-03       Impact factor: 6.312

Review 8.  Role of apolipoprotein E in anxiety.

Authors:  Jacob Raber
Journal:  Neural Plast       Date:  2007       Impact factor: 3.599

9.  Unipolar late-onset depression: A comprehensive review.

Authors:  Konstantinos N Fountoulakis; Ruth O'Hara; Apostolos Iacovides; Christopher P Camilleri; Stergios Kaprinis; George Kaprinis; Jerome Yesavage
Journal:  Ann Gen Hosp Psychiatry       Date:  2003-12-16

Review 10.  The potential applications of Apolipoprotein E in personalized medicine.

Authors:  Sylvia Villeneuve; Diane Brisson; Natalie L Marchant; Daniel Gaudet
Journal:  Front Aging Neurosci       Date:  2014-07-08       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.